I was shocked to hear the National Institute for Health and Clinical Excellence (Nice) has rejected the views of thousands of people by failing to reconsider its proposal to withdraw Alzheimer's drug treatments from the NHS.
More than 8,000 people wrote to Nice following the publication of draft guidance issued in March - an unprecedented response.
But despite being overwhelmed with personal and professional testimonies highlighting the benefits of these drugs, Nice has decided to prolong the uncertainty for people with dementia and their carers while it re-examines the facts.
The Alzheimer's Society believes there is overwhelming evidence to show these drugs work and, at just £2.50 a day, are good value for money.
Why won't Nice listen? Because our Government will save an awful lot of money on benefits and pensions when we are dead.
-Eileen Rye, Brighton
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article